MARX Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	22.46	74.67	152.83	27.73	0.18
Short-Term Investments	5	3.5	-	-	-
Cash & Short-Term Investments	27.46	78.17	152.83	27.73	0.18
Cash Growth	-71.97%	-48.85%	451.08%	15479.78%	-
Accounts Receivable	89.79	120.02	98.42	54.95	-
Other Receivables	8.41	3.92	4.62	-	-
Receivables	98.19	123.94	103.04	54.95	-
Inventory	249.39	164.31	70	12	-
Prepaid Expenses	14.19	35.93	13.98	0.83	-
Other Current Assets	7.12	4.95	3.19	0.56	-
Total Current Assets	396.35	407.3	343.04	96.07	0.18
Property, Plant & Equipment	221.99	217.19	4.26	4.73	-
Long-Term Investments	-	-	-	-	13.5
Goodwill	26.25	26.25	5.37	-	-
Other Intangible Assets	71.38	65.36	30.1	-	-
Long-Term Deferred Tax Assets	8.29	6.56	4.92	1.94	0.09
Other Long-Term Assets	8.76	8.54	7.15	0.45	0.03
Total Assets	733.01	731.2	394.85	103.19	13.8
Accounts Payable	55.18	88.88	23.72	5.26	-
Accrued Expenses	40.3	58.25	39.77	12.98	0.5
Short-Term Debt	176	98	-	10	-
Current Portion of Long-Term Debt	16.64	5.27	-	-	-
Current Portion of Leases	4.85	3.9	1.26	2.97	-
Current Income Taxes Payable	-	-	-	3.41	-
Current Unearned Revenue	39.12	40.26	25.08	2.28	-
Other Current Liabilities	10.28	13.87	11.2	4.6	0.16
Total Current Liabilities	342.36	308.43	101.04	41.5	0.66
Long-Term Debt	171.69	165.04	-	-	-
Long-Term Leases	3.83	5.11	0.62	0.87	-
Long-Term Deferred Tax Liabilities	1.33	1.38	0.2	0.08	-
Total Liabilities	519.21	479.95	101.86	42.45	0.66
Common Stock	126.5	126.5	124.51	40.8	8.05
Additional Paid-In Capital	124.23	220.48	186.03	17.98	3.21
Retained Earnings	-36.92	-95.73	-17.55	1.95	1.89
Shareholders' Equity	213.8	251.25	292.99	60.73	13.14
Total Liabilities & Equity	733.01	731.2	394.85	103.19	13.8
Total Debt	373	277.32	1.88	13.84	-
Net Cash (Debt)	-345.55	-199.15	150.94	13.89	0.18
Net Cash Growth	-	-	986.39%	7705.62%	-
Net Cash Per Share	-0.69	-0.40	0.47	0.04	0.01
Filing Date Shares Outstanding	505.98	505.98	498.06	163.21	32.18
Total Common Shares Outstanding	505.98	505.98	498.06	163.21	32.18
Working Capital	53.98	98.87	242.01	54.57	-0.48
Book Value Per Share	0.42	0.50	0.59	0.37	0.41
Tangible Book Value	116.17	159.64	257.52	60.73	13.14
Tangible Book Value Per Share	0.23	0.32	0.52	0.37	0.41
Land	129.46	129.46	-	-	-
Buildings	69.13	69.13	-	-	-
Machinery	11.74	9.13	2.7	1.03	-
Construction In Progress	-	-	0	0.02	-
Leasehold Improvements	8.1	3.75	1.1	0.44	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.